These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2896639)
1. Proton n.m.r. investigation of conformational influence of penicillamine residues on the disulfide ring system of opioid receptor selective somatostatin derivatives. Sugg EE; Tourwe D; Kazmierski W; Hruby VJ; Van Binst G Int J Pept Protein Res; 1988 Feb; 31(2):192-200. PubMed ID: 2896639 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors. Pelton JT; Kazmierski W; Gulya K; Yamamura HI; Hruby VJ J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079 [TBL] [Abstract][Full Text] [Related]
3. Conformation of D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NH2 (CTP-NH2), a highly selective mu-opioid antagonist peptide, by 1H and 13C n.m.r. Pelton JT; Whalon M; Cody WL; Hruby VJ Int J Pept Protein Res; 1988 Feb; 31(2):109-15. PubMed ID: 2896638 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors. Kazmierski W; Wire WS; Lui GK; Knapp RJ; Shook JE; Burks TF; Yamamura HI; Hruby VJ J Med Chem; 1988 Nov; 31(11):2170-7. PubMed ID: 2903246 [TBL] [Abstract][Full Text] [Related]
5. A topographical model of mu-opioid and brain somatostatin receptor selective ligands. NMR and molecular dynamics studies. Kazmierski WM; Ferguson RD; Lipkowski AW; Hruby VJ Int J Pept Protein Res; 1995; 46(3-4):265-78. PubMed ID: 8537180 [TBL] [Abstract][Full Text] [Related]
6. Superactive octapeptide somatostatin analogs containing tryptophan at position 1. Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520 [TBL] [Abstract][Full Text] [Related]
7. Conformational study of a somatostatin analogue by high-field n.m.r. spectroscopy, in aqueous solution. Wynants C; Sugg E; Hruby VJ; Van Binst G Int J Pept Protein Res; 1987 Oct; 30(4):541-7. PubMed ID: 2892808 [TBL] [Abstract][Full Text] [Related]
8. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons. Chieng B; Connor M; Christie MJ Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906 [TBL] [Abstract][Full Text] [Related]
9. Conformational analyses of sandostatin analogs containing stereochemical changes in positions 6 or 8. Mattern RH; Zhang L; Rueter JK; Goodman M Biopolymers; 2000 May; 53(6):506-22. PubMed ID: 10775066 [TBL] [Abstract][Full Text] [Related]
11. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach. Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337 [TBL] [Abstract][Full Text] [Related]
12. Conformationally restricted analogs of somatostatin with high mu-opiate receptor specificity. Pelton JT; Gulya K; Hruby VJ; Duckles SP; Yamamura HI Proc Natl Acad Sci U S A; 1985 Jan; 82(1):236-9. PubMed ID: 2857488 [TBL] [Abstract][Full Text] [Related]
13. Opioid receptor affinity and selectivity effects of second residue and carboxy terminal residue variation in a cyclic disulfide-containing opioid tetrapeptide. Heyl DL; Omnaas JR; Sobczyk-Kojiro K; Medzihradsky F; Smith CB; Mosberg HI Int J Pept Protein Res; 1991 Mar; 37(3):224-9. PubMed ID: 1651290 [TBL] [Abstract][Full Text] [Related]
14. Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: development of a ligand with high delta opioid receptor selectivity and affinity. Mosberg HI; Omnaas JR; Medzihradsky F; Smith CB Life Sci; 1988; 43(12):1013-20. PubMed ID: 2845204 [TBL] [Abstract][Full Text] [Related]
15. Comparison of conformational properties of linear and cyclic delta selective opioid ligands DTLET (Tyr-D X Thr-Gly-Phe-Leu-Thr) and DPLPE (Tyr-c[D X Pen-Gly-Phe-Pen]) by 1H n.m.r. spectroscopy. Belleney J; Roques BP; Fournie-Zaluski MC Int J Pept Protein Res; 1987 Sep; 30(3):356-64. PubMed ID: 3692682 [TBL] [Abstract][Full Text] [Related]
16. Conformation-activity relationships of cyclo-constrained micro/delta opioid agonists derived from the N-terminal tetrapeptide segment of dermorphin/deltorphin. Rodziewicz-Motowidło S; Czaplewski C; Luczak S; Ciarkowski J J Pept Sci; 2008 Aug; 14(8):898-902. PubMed ID: 18338322 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of receptors for somatostatin in various tumors using different analogs. Srkalovic G; Cai RZ; Schally AV J Clin Endocrinol Metab; 1990 Mar; 70(3):661-9. PubMed ID: 1968467 [TBL] [Abstract][Full Text] [Related]